Percutaneous approaches to valvular heart disease after previous cardiac surgery

John M. Stulak, Hartzell V Schaff

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

While open surgical correction is the best treatment for most patients with valvular heart disease, there have been recent technical advances that permit percutaneous approaches to valve replacement and valve repair in selected circumstances. The most widely accepted catheter-based therapy for valvular heart disease is percutaneous balloon dilatation for rheumatic mitral valve stenosis, and this might be applicable to some patients who require relief of mitral valve stenosis after previous aortic or tricuspid valve surgery. As discussed earlier, degenerative mitral valve disease is the most common mitral valve etiology in Western populations, and considerable effort has been extended toward catheter-based methods for repair of mitral valve prolapse. Patients with aortic valve stenosis constitute the largest population of patients who might be considered for transcatheter therapy. Percutaneous and transapical insertion of collapsible bioprostheses has been used widely in elderly high-risk patients, and many of these patients have had previous cardiac surgery [1, 2].

Original languageEnglish (US)
Title of host publicationRedo Cardiac Surgery in Adults
PublisherSpringer New York
Pages195-200
Number of pages6
Volume9781461413264
ISBN (Print)9781461413264, 1461413257, 9781461413257
DOIs
StatePublished - Jun 1 2012

Fingerprint

Heart Valve Diseases
Thoracic Surgery
Mitral Valve Stenosis
Mitral Valve
Catheters
Bioprosthesis
Mitral Valve Prolapse
Tricuspid Valve
Aortic Valve Stenosis
Aortic Valve
Population
Dilatation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stulak, J. M., & Schaff, H. V. (2012). Percutaneous approaches to valvular heart disease after previous cardiac surgery. In Redo Cardiac Surgery in Adults (Vol. 9781461413264, pp. 195-200). Springer New York. https://doi.org/10.1007/978-1-4614-1326-4_21

Percutaneous approaches to valvular heart disease after previous cardiac surgery. / Stulak, John M.; Schaff, Hartzell V.

Redo Cardiac Surgery in Adults. Vol. 9781461413264 Springer New York, 2012. p. 195-200.

Research output: Chapter in Book/Report/Conference proceedingChapter

Stulak, JM & Schaff, HV 2012, Percutaneous approaches to valvular heart disease after previous cardiac surgery. in Redo Cardiac Surgery in Adults. vol. 9781461413264, Springer New York, pp. 195-200. https://doi.org/10.1007/978-1-4614-1326-4_21
Stulak JM, Schaff HV. Percutaneous approaches to valvular heart disease after previous cardiac surgery. In Redo Cardiac Surgery in Adults. Vol. 9781461413264. Springer New York. 2012. p. 195-200 https://doi.org/10.1007/978-1-4614-1326-4_21
Stulak, John M. ; Schaff, Hartzell V. / Percutaneous approaches to valvular heart disease after previous cardiac surgery. Redo Cardiac Surgery in Adults. Vol. 9781461413264 Springer New York, 2012. pp. 195-200
@inbook{48b78f93a67a4bce97b167ab1d8ef8d4,
title = "Percutaneous approaches to valvular heart disease after previous cardiac surgery",
abstract = "While open surgical correction is the best treatment for most patients with valvular heart disease, there have been recent technical advances that permit percutaneous approaches to valve replacement and valve repair in selected circumstances. The most widely accepted catheter-based therapy for valvular heart disease is percutaneous balloon dilatation for rheumatic mitral valve stenosis, and this might be applicable to some patients who require relief of mitral valve stenosis after previous aortic or tricuspid valve surgery. As discussed earlier, degenerative mitral valve disease is the most common mitral valve etiology in Western populations, and considerable effort has been extended toward catheter-based methods for repair of mitral valve prolapse. Patients with aortic valve stenosis constitute the largest population of patients who might be considered for transcatheter therapy. Percutaneous and transapical insertion of collapsible bioprostheses has been used widely in elderly high-risk patients, and many of these patients have had previous cardiac surgery [1, 2].",
author = "Stulak, {John M.} and Schaff, {Hartzell V}",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/978-1-4614-1326-4_21",
language = "English (US)",
isbn = "9781461413264",
volume = "9781461413264",
pages = "195--200",
booktitle = "Redo Cardiac Surgery in Adults",
publisher = "Springer New York",

}

TY - CHAP

T1 - Percutaneous approaches to valvular heart disease after previous cardiac surgery

AU - Stulak, John M.

AU - Schaff, Hartzell V

PY - 2012/6/1

Y1 - 2012/6/1

N2 - While open surgical correction is the best treatment for most patients with valvular heart disease, there have been recent technical advances that permit percutaneous approaches to valve replacement and valve repair in selected circumstances. The most widely accepted catheter-based therapy for valvular heart disease is percutaneous balloon dilatation for rheumatic mitral valve stenosis, and this might be applicable to some patients who require relief of mitral valve stenosis after previous aortic or tricuspid valve surgery. As discussed earlier, degenerative mitral valve disease is the most common mitral valve etiology in Western populations, and considerable effort has been extended toward catheter-based methods for repair of mitral valve prolapse. Patients with aortic valve stenosis constitute the largest population of patients who might be considered for transcatheter therapy. Percutaneous and transapical insertion of collapsible bioprostheses has been used widely in elderly high-risk patients, and many of these patients have had previous cardiac surgery [1, 2].

AB - While open surgical correction is the best treatment for most patients with valvular heart disease, there have been recent technical advances that permit percutaneous approaches to valve replacement and valve repair in selected circumstances. The most widely accepted catheter-based therapy for valvular heart disease is percutaneous balloon dilatation for rheumatic mitral valve stenosis, and this might be applicable to some patients who require relief of mitral valve stenosis after previous aortic or tricuspid valve surgery. As discussed earlier, degenerative mitral valve disease is the most common mitral valve etiology in Western populations, and considerable effort has been extended toward catheter-based methods for repair of mitral valve prolapse. Patients with aortic valve stenosis constitute the largest population of patients who might be considered for transcatheter therapy. Percutaneous and transapical insertion of collapsible bioprostheses has been used widely in elderly high-risk patients, and many of these patients have had previous cardiac surgery [1, 2].

UR - http://www.scopus.com/inward/record.url?scp=84949176762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949176762&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1326-4_21

DO - 10.1007/978-1-4614-1326-4_21

M3 - Chapter

AN - SCOPUS:84949176762

SN - 9781461413264

SN - 1461413257

SN - 9781461413257

VL - 9781461413264

SP - 195

EP - 200

BT - Redo Cardiac Surgery in Adults

PB - Springer New York

ER -